Coupons, Vouchers Are Dilemmas For Industry Under Vermont Drug Sample Reporting Law
Executive Summary
As pharma companies begin to implement a Vermont law requiring them to report who receives their drug samples, they remain uncertain about some of the details.
You may also be interested in...
Physician Payments Sunshine Rule From CMS Expected By Year's End
Pharmaceutical companies will have a little more than a year to put together data to comply with CMS regulations for reporting payments made to physicians if the agency meets its current timeline for issuing the rules.
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.